Klostranec, Jesse M.
Vucevic, Diana
Crawley, Adrian P.
Venkatraghavan, Lashmi
Sobczyk, Olivia
Duffin, James
Sam, Kevin
Holmes, Royce
Fedorko, Ludwik
Mikulis, David J.
Fisher, Joseph A.
Article History
Received: 25 July 2020
Accepted: 21 October 2020
First Online: 12 November 2020
Competing interests
: Thornhill Medical Inc. developed the ClearMate<sup>TM</sup> for the treatment of carbon monoxide poisoning and made a unit available on request at no cost for this study. JAF, OS, JD, LF, and DJM are appointees at the University of Toronto and employees of and/or own shares in Thornhill Medical Inc, which is a for profit spin-off from the University Health Network (University of Toronto), which continues to own the IP. JMK, DV, APC, LV, KS, and RH have no competing interests.